Alembic Pharma ropes in G Krishnan as CFO

Vadodara: Alembic Pharma has appointed G Krishnan as the Chief Financial Officer (CFO) and Key Managerial Personnel of the Company.

A seasoned finance leader, Krishnan is a qualified CA, CS and CMA, with over 22 years of diverse experience spanning pharmaceuticals, life sciences, telecom and social sector organizations.

Prior to joining Alembic, he was working with Syngene International Limited since May 2020, as Vice President and Chief Financial Officer of Syngene Scientific Solutions Limited, where he has played a pivotal role in driving strategy, business finance, mergers & acquisitions, governance and risk management. Previously, he has held key leadership roles at Vodafone and Tata Trusts. He brings expertise in business finance, mergers & acquisitions, implementation of scalable systems, governance frameworks and managing diverse finance teams.

His appointment comes as R. K. Baheti, Director – Finance and CFO has relinquished the position of CFO. However, Baheti will continue to serve as an Executive Director of the Company, as per the terms of his appointment.

Read also: Alembic Pharma bags USFDA nod for cancer injection Doxorubicin Hydrochloride Liposome

In May, Viraj Save, Executive Vice President - Sales and Marketing resigned from his position at Alembic Pharma.

Read also: Alembic Pharma Viraj Save resigned as Executive Vice President - Sales and Marketing

Headquartered in India, Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company. It is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.

Read also: Alembic Pharma bags USFDA nod for cancer injection Doxorubicin Hydrochloride Liposome